Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27

Eloxx Pharmaceuticals GAAP EPS of -$0.66

2026/08/11

Questerre Energy reports Q2 results

2026/08/11

PagSeguro GAAP EPS of R$1.96, revenue of R$5.08B

2026/08/11

Firm Capital Property Trust reports Q2 results

2026/08/11